Vetmab Biosciences
PrivateLast Round
Seed
Sep 17, 2026
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Vetmab Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Early Funding round in April 2025.
Vetmab Biosciences is a biotechnology company that develops monoclonal antibody therapeutics for dogs and cats.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetmab Biosciences Comparables
Compare Vetmab Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetigenics Inc. | 84% | |
| Antigenesis Biologics Ltd | 84% | |
| Immuvera Therapeutics | 82% |
For institutional investors. Book with your work email.
Vetmab Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 17, 2026 | ||||
| Early Funding | Apr 9, 2025 | ||||
| Seed | Aug 9, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 17, 2026
$11.4M raised in Seed round.
- May 18, 2026
Monthly visitors increased 47% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 12, 2026
Vetmab Biosciences, Inc. appoints Katja Buhrer as Chief Operating Officer on Nov 12th '26 in California, where she oversees corporate operations, strategy, business development, and investor relations.
For institutional investors. Book with your work email.
Vetmab Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vetmab Biosciences's valuation, stock price, and market status.
Is Vetmab Biosciences a public or private company?
Vetmab Biosciences is a private company.
What is the current stock price of Vetmab Biosciences?
Vetmab Biosciences is a private company, so its shares have no public market price. Caplight tracks Vetmab Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vetmab Biosciences worth (valuation)?
Valuation information for Vetmab Biosciences is not publicly available.
Can I buy Vetmab Biosciences stock?
Vetmab Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vetmab Biosciences's last funding round?
Vetmab Biosciences's most recent funding round was Seed on September 17, 2026.
Who are the main investors in Vetmab Biosciences?
Investor information for Vetmab Biosciences is not publicly disclosed.
Will Vetmab Biosciences IPO soon?
No public IPO plans have been announced for Vetmab Biosciences.
How can I track Vetmab Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Vetmab Biosciences's shares on secondary markets.